A subepithelial lesion algorithm for endoscopic (SAFE) resection in the upper gastrointestinal tract

Abstract

Background Complete excision of upper gastrointestinal subepithelial lesions (U-SELs) eliminates diagnostic uncertainty, obviates the need for surveillance, and may be necessary for definitive diagnosis and management. Current guidelines lack precision and cohesion, and surgery is associated with significant morbidity. We describe and report on the outcomes of our SEL algorithm for endoscopic (SAFE) resection.

Methods U-SELs were enrolled prospectively over 115 months until March 2023. All subjects underwent axial (computed tomography) imaging and endoscopic ultrasonography (EUS) to exclude a large exophytic component or invasion into local structures, and assess for muscularis propria (MP) involvement.

Results 106 U-SELs (41 esophageal, 65 gastric) were resected (mean patient age 60.6 [SD 13.4]; 51.9% male). Esophageal U-SELs underwent endoscopic submucosal dissection (ESD; n = 22) or submucosal tunneling endoscopic resection (STER) if MP involvement was suspected (n = 19). Gastric U-SELs underwent STER (n = 6 at cardia), ESD (n = 47), or exposing endoscopic full-thickness resection (e-EFTR; n = 12). Technical success rates were 97.6% and 92.3%, respectively. Among the noncardiac gastric U-SELs, five resections (9.6%) were completed laparoscopically owing to deep and broad full-thickness involvement; five (9.6%) required laparoscopic gastrotomy and surgical retrieval after successful resection and closure owing to a large lesion size (mean 47 mm). There was no delayed bleeding, perforation, or recurrence at 13 months.

Conclusion U-SELs may be effectively and safely treated by endoscopic resection. The SAFE approach provides a framework that facilitates structured decision-making. Esophageal U-SELs suspected of involving the MP should undergo STER. Gastric SELs are best managed by ESD, with a view to proceeding to e-EFTR. A laparoscopic upper gastrointestinal surgeon should be available in case surgical retrieval of the specimen or laparoscopic completion is required.

Publikationsverlauf

Eingereicht: 23. August 2023

Angenommen nach Revision: 19. Juli 2024

Accepted Manuscript online:
19. Juli 2024

Artikel online veröffentlicht:
01. Oktober 2024

• References

• 1 Faulx AL, Kothari S, Acosta RD. et al. The role of endoscopy in subepithelial lesions of the GI tract. Gastrointest Endosc 2017; 85: 1117-1132 DOI: 10.1016/j.gie.2017.02.022. (PMID: 28385194)
• 2 Aslanian HR, Sethi A, Bhutani MS. et al. ASGE guideline for endoscopic full-thickness resection and submucosal tunnel endoscopic resection. VideoGIE 2019; 4: 343-350 DOI: 10.1016/j.vgie.2019.03.010. (PMID: 31388606)
• 3 Deprez PH, Moons LM, OʼToole D. et al. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54: 412-429 DOI: 10.1055/a-1751-5742. (PMID: 35180797)
• 4 Jacobson BC, Bhatt A, Greer KB. et al. ACG Clinical Guideline: diagnosis and management of gastrointestinal subepithelial lesions. Am J Gastroenterol 2023; 118: 46-58 DOI: 10.14309/ajg.0000000000002100. (PMID: 36602835)
• 5 Sharzehi K, Sethi A, Savides T. AGA clinical practice update on management of subepithelial lesions encountered during routine endoscopy: expert review. Clin Gastroenterol Hepatol 2022; 20: 2435-2443 DOI: 10.1016/j.cgh.2022.05.054. (PMID: 35842117)
• 6 Lee CM, Kim H-H. Minimally invasive surgery for submucosal (subepithelial) tumors of the stomach. World J Gastroenterol 2014; 20: 13035 DOI: 10.3748/wjg.v20.i36.13035. (PMID: 25278697)
• 7 Kong S-H, Yang H-K. Surgical treatment of gastric gastrointestinal stromal tumor. J Gastric Cancer 2013; 13: 3-18 DOI: 10.5230/jgc.2013.13.1.3. (PMID: 23610714)
• 8 Low DE, Kuppusamy MK, Alderson D. et al. Benchmarking complications associated with esophagectomy. Ann Surg 2019; 269: 291-298
• 9 Davis SS, Babidge WJ, Kiermeier A. et al. Perioperative mortality following oesophagectomy and pancreaticoduodenectomy in Australia. World J Surg 2018; 42: 742-748 DOI: 10.1007/s00268-017-4204-3. (PMID: 28884329)
• 10 Baker A, Wooten L-A, Malloy M. Nutritional considerations after gastrectomy and esophagectomy for malignancy. Curr Treat Options Oncol 2011; 12: 85-95 DOI: 10.1007/s11864-010-0134-0. (PMID: 21264689)
• 11 Song JH, Kim SG, Chung SJ. et al. Risk of progression for incidental small subepithelial tumors in the upper gastrointestinal tract. Endoscopy 2015; 47: 675-679 DOI: 10.1055/s-0034-1391967. (PMID: 25961444)
• 12 Bas-Cutrina F, Casellas-Grau A, Videla S. et al. Half of the patients with subepithelial tumours present borderline or pathologic anxiety-distress and carcinophobia: multicentre cohort study. Revista Espanola de Enfermedades Digestivas 2022; 115: 80-84
• 13 Kushnir VM, Keswani RN, Hollander TG. et al. Compliance with surveillance recommendations for foregut subepithelial tumors is poor: results of a prospective multicenter study. Gastrointest Endosc 2015; 81: 1378-1384
• 14 von Elm E, Altman DG, Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573-577 DOI: 10.1016/j.jclinepi.2007.11.008. (PMID: 18313558)
• 15 Hwang JH, Saunders MD, Rulyak SJ. et al. A prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial masses. Gastrointest Endosc 2005; 62: 202-208 DOI: 10.1016/s0016-5107(05)01567-1. (PMID: 16046979)
• 16 Burgess NG, Bassan MS, McLeod D. et al. Deep mural injury and perforation after colonic endoscopic mucosal resection: a new classification and analysis of risk factors. Gut 2017; 66: 1779-1789 DOI: 10.1136/gutjnl-2015-309848. (PMID: 27464708)
• 17 Zhu Y, Xu M-D, Xu C. et al. Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin. Surg Endosc 2020; 34: 159-169